Chongqing Carelife Pharmaceutical Co., Ltd. (CCPC) which is owned by YAOPHARMA Co., Ltd. is an internationalized and export-oriented high-tech enterprise. CCPC is mainly engaged in manufacturing and distribution of APIs and Intermediates.
     
CCPC owns state-of-the-art facilities for APIs manufacturing, with professionals and technicians working in registration, production and quality management. CCPC has established a rigid quality assurance system and stick to introduce scientific management. CCPC is equipped with advanced analytical instruments which are made in US, Europe and Japan. CCPC strictly follows up ICH guideline & cGMP in all-round way.

At present, many API products have been respectively inspected and/or approved by USFDA, EDQM, Japan PMDA, Australia TGA, Canada TPD, Germany Health Authority, India Ministry of Health. CCPC has filed more then 80 DMFs with the relevant drug agencies.

CCPC is devoted to the development of the global market. Since entering international market in the early 1990s, more than 90% of its API products are sold to the regulated markets such as North America, Europe, Australia, Japan and ect. At present, our market share in Asia, South America is also increasing. We have established substantial cooperation with several famous pharmaceutical companies enjoying international reputation in the field of pharmaceutical research & development and market exploitation.

All the staff of CCPC will keep the principle of regular management, quality first and production safety, enlarging and strengthening the domestic and foreign market with positive and steady steps.